Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-01 8:42 pm Purchase | 13D | VIVANI MED INC VANI | Williams Gregg | 23,597,129 38.9% | 23,597,129 (New Position) | View |
| 2023-04-25 5:28 pm Purchase | 13D | VIVANI MED INC VANI | Bolck Joachim Eberhard | 5,597,123 11.03% | 5,597,123 (New Position) | View |
| 2022-09-01 9:34 pm Purchase | 13D | SECOND SIGHT MEDICAL PRODUCTS EYES | Williams Gregg | 20,909,620 41.22% | 3,615,941 (+20.91%) | View |
| 2022-08-31 6:49 pm Purchase | 13D | VIVANI MED INC VANI | Mendelsohn Adam | 3,712,573 7.51% | 3,712,573 (New Position) | View |
| 2022-07-22 5:06 pm Sale | 13D | SECOND SIGHT MEDICAL PRODUCTS EYES | Williams Gregg | 17,293,679 38.06% | -110,072,075 (-86.42%) | View |
| 2022-01-13 10:36 am Sale | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 0 0% | -3,300,000 (Position Closed) | View |
| 2021-06-28 10:01 am Purchase | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 3,300,000 8.71% | 3,300,000 (New Position) | View |
| 2021-02-11 4:06 pm Sale | 13G | SECOND SIGHT MED PRODS INC EYES | Altium Capital Management LP | 0 0% | -2,200,000 (Position Closed) | View |
| 2021-01-20 11:01 am Sale | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 0 0% | -2,200,000 (Position Closed) | View |
| 2021-01-08 5:22 pm Purchase | 13D | SECOND SIGHT MED PRODS INC EYES | Pixium Vision S.A. | 6,978,886 30.1% | 6,978,886 (New Position) | View |
| 2021-01-05 5:08 pm Unchanged | 13G | SECOND SIGHT MED PRODS INC EYES | SABBY MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2020-05-08 12:04 pm Purchase | 13G | SECOND SIGHT MED PRODS INC EYES | Altium Capital Management LP | 2,200,000 9.5% | 2,200,000 (New Position) | View |
| 2020-05-05 09:17 am Purchase | 13G | SECOND SIGHT MED PRODS INC EYES | Empery Asset Management LP | 2,200,000 9.51% | 2,200,000 (New Position) | View |
| 2020-05-01 08:47 am Purchase | 13G | SECOND SIGHT MEDICAL PRODUCTS EYES | SABBY MANAGEMENT LLC | 2,200,000 11% | 2,200,000 (New Position) | View |
| 2020-02-14 11:37 am Unchanged | 13G | SECOND SIGHT MEDICAL PRODUCTS EYES | Versant Affiliates Fund II-A LP | 4,492,975 3.6% | 0 (Unchanged) | View |
| 2019-08-29 4:50 pm Purchase | 13D | SECOND SIGHT MEDICAL PRODUCTS EYES | Williams Gregg | 127,365,754 73.7% | 1,434,335 (+1.14%) | View |